Literature DB >> 3385436

Diminished concentrations of ganglioside N-acetylneuraminic acid (G-NeuAc) in cerebellum of young rats receiving chronic administration of methylmalonic acid.

M Wajner1, E C Brites, J C Dutra, M S Buchalter, A H Pons, R F Pires, L E Wannmacher, A Rosa Júnior, V M Trindade, C M Wannmacher.   

Abstract

Sustained levels of methylmalonate comparable to those of human methylmalonic acidemia were achieved in the blood of young rats from the 5th till the 25th day of life by injecting them subcutaneously with buffered methylmalonic acid (MMA) twice a day at 8-h intervals. A matched group of rats (controls) was treated with saline. The animals were weighed and killed by decapitation at 25 days of age. Cerebellum and cerebrum were weighed and their contents of protein, DNA and ganglioside N-acetylneuraminic acid (G-NeuAc), as well as the protein/DNA ratio determined. Body weight, cerebral and cerebellar weight did not differ in both groups. The concentrations of protein, DNA and the protein/DNA ratio were also similar in the experimental and control groups. The results indicate that MMA per se does not interfere with the appetite of the animals and does not affect cellular proliferation and growth in cerebrum and cerebellum. We also found that G-NeuAc concentration is significantly reduced in the cerebellum. Therefore, since a deficit of an important component of brain closely related to the dendritic surface (synaptogenesis) occurs in MMA-treated rats, it is tempting to speculate whether this alteration may be associated or even partly responsible for the mental retardation in patients affected by methylmalonic acidemia.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3385436     DOI: 10.1016/0022-510x(88)90159-1

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  7 in total

Review 1.  Mitochondrial energy metabolism in neurodegeneration associated with methylmalonic acidemia.

Authors:  Daniela R Melo; Alicia J Kowaltowski; Moacir Wajner; Roger F Castilho
Journal:  J Bioenerg Biomembr       Date:  2011-02       Impact factor: 2.945

2.  Inhibition of rat brain lipid synthesis in vitro by 4-hydroxybutyric acid.

Authors:  A R Silva; C Ruschel; C Helegda; A M Brusque; C M Wannmacher; M Wajner; C S Dustra-Filho
Journal:  Metab Brain Dis       Date:  1999-09       Impact factor: 3.584

3.  Methylmalonic and malonic aciduria in a dog with progressive encephalomyelopathy.

Authors:  M Podell; G D Shelton; W L Nyhan; S O Wagner; A Genders; M Oglesbee; W R Fenner
Journal:  Metab Brain Dis       Date:  1996-09       Impact factor: 3.584

4.  Inhibition of succinate dehydrogenase and beta-hydroxybutyrate dehydrogenase activities by methylmalonate in brain and liver of developing rats.

Authors:  J C Dutra; C S Dutra-Filho; S E Cardozo; C M Wannmacher; J J Sarkis; M Wajner
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

5.  Diminished concentration of the NF-H subunit of neurofilaments in cerebral cortex of rats chronically treated with proline, methylmalonate and phenylalanine plus alpha-methylphenylalanine.

Authors:  M A Rubin; C M Wannmacher; G B Valente; M M Camargo; R P Pureur
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

6.  Ganglioside alterations in the central nervous system of rats chronically injected with methylmalonic and propionic acids.

Authors:  V M T Trindade; A M Brusque; J R Raasch; L E Pettenuzzo; H P Rocha; C M D Wannmacher; M Wajne
Journal:  Metab Brain Dis       Date:  2002-06       Impact factor: 3.584

Review 7.  Succinic Semialdehyde Dehydrogenase Deficiency: An Update.

Authors:  Miroslava Didiášová; Antje Banning; Heiko Brennenstuhl; Sabine Jung-Klawitter; Claudio Cinquemani; Thomas Opladen; Ritva Tikkanen
Journal:  Cells       Date:  2020-02-19       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.